Cataract Clinical Trial
Official title:
Use of Human Lens Material for the Study of Nuclear Cataracts
Cataract, in which the lens of the eye is opacified, is the major cause of blindness. This
study will examine protein material of the lens called crystallins to try to determine what
causes nuclear cataracts, a type of cataract that forms in the central lens nucleus.
Men and women age 45 years or older with a cataract may be eligible for this study.
Candidates will be screened to determine what type of cataract they have and will undergo a
complete eye examination, including a vision test, eye pressure test, and examination of the
lens and retina.
Patients selected for study will have a complete physical and eye examination, including
photography of various parts of the eye, and ultrasound measurements of the eye. They will
then have cataract surgery, either with or without intraocular lens implantation, and will
have follow-up examinations 1 week, 3 weeks, 5 weeks and 8 weeks after surgery.
Tissue from the lenses removed during surgery will be given to NEI scientists for research
on the causes of age-related nuclear cataracts.
Progress has been made in elucidating causative factors for some cataracts but little is yet
known about those factors involved in development of aging-related nuclear cataracts. The
predominant theory of nuclear cataractogenesis is that the lens crystallins accumulate
covalent modifications which ultimately lead to increased light scattering. This theory is
based on several lines of evidence. Crystallins, the predominant components of the lens, are
present at very high concentration and determine the refractive properties of the lens. A
relationship between crystallin alterations and cataract formation comes from studies on
animal cataract models where mutations in crystallin genes have been identified. Numerous
studies have also demonstrated that covalent modification of crystallins occurs in the human
lens. These modifications are reported to be developmentally related, age related and/or the
result of toxic environmental influences. Data from this lab demonstrated that the human
lens crystallins undergo extensive covalent modification as part of normal lens fiber cell
maturation. Crystallin modifications that cause cataracts would have to be superimposed on
these normally occurring modifications.
We have begun a study under the protocol entitled "Use of Human Lens Material for Possible
Causes of Cataract" to compare crystallins in nuclear cataracts with those in normal lenses.
The goal was to identify uniquely altered crystallins, isolate the modified species and
determine the covalent modifications that could possibly be involved in cataract formation.
Surprisingly, our preliminary findings indicated that the pattern of protein spots on a
2-dimensional display of the total lens proteins (soluble, water insoluble and membrane) in
the nuclear region of nuclear cataracts is essentially the same as found in the nucleus of
normal lenses. Only the relative concentrations of these protein species varied. The number
of pure nuclear cataracts available was too few 1) to determine the relationship between
nuclear cataracts and crystallin covalent modification and 2) to establish the significance
of concentration differences in crystallin species between normal lenses and nuclear
cataracts. Therefore, the purpose of this protocol is to recruit enough subjects with pure
nuclear cataracts to complete this study which should provide significant insights into the
mechanisms underlying nuclear cataract.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |